Biopharmaceutical major Biocon has elevated Chief Financial Officer Siddharth Mittal as its chief executive officer and joint managing director, with effect from December 1. Mittal had been serving as the company’s CFO since August 2014.
"Siddharth’s strong leadership qualities, comprehensive understanding of various aspects of the business, deep financial insights and robust operational experience make him an excellent fit for the role of CEO to lead Biocon through its next phase of growth. I am confident that in this new role he will build immense value for Biocon and its stakeholders,” said Kiran Mazumdar-Shaw, CMD, Biocon.
According to the company,